Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Abrocitinib may effectively treat stubborn alopecia universalis.

JAK inhibitors are effective and safe for treating severe alopecia areata.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Apremilast may help treat hair loss in alopecia areata.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Adalimumab can cause complete hair loss in rare cases.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Adalimumab improved folliculitis decalvans in most patients.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.